CSIMarket


Iovance Biotherapeutics Inc   (IOVA)
Other Ticker:  
 

Iovance Biotherapeutics Inc

IOVA's Fundamental analysis








Looking into Iovance Biotherapeutics Inc growth rates, revenue grew in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 960

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -3.99 %



More on IOVA's Growth


Iovance Biotherapeutics Inc
realized net loss in trailing twelve months.

Iovance Biotherapeutics Inc realized cash outflow of $ -0.24per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2748.54.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.6.


More on IOVA's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 25.85
 Tangible Book Value (Per Share $) 1.51

Iovance Biotherapeutics Inc
realized net loss in trailing twelve months.

Iovance Biotherapeutics Inc realized cash outflow of $ -0.24per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2748.54.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.6.

Iovance Biotherapeutics Inc Price to Book Ratio is at 5.59 lower than Indusry Avg. of 859.18. and higher than S&P 500 Avg. of -1999.75

More on IOVA's Valuation

  Market Capitalization (Millions $) 3,268
  Shares Outstanding (Millions) 235
  Employees -
  Revenues (TTM) (Millions $) 1
  Net Income (TTM) (Millions $) -444
  Cash Flow (TTM) (Millions $) -57
  Capital Exp. (TTM) (Millions $) -22
  Total Debt (Millions $) 1
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 25.85
  Tangible Book Value (Per Share $) 1.51

  Market Capitalization (Millions $) 3,268
  Shares Outstanding (Millions) 235
  Employees -
  Revenues (TTM) (Millions $) 1
  Net Income (TTM) (Millions $) -444
  Cash Flow (TTM) (Millions $) -57
  Capital Exp. (TTM) (Millions $) -22





  Ratio
   Capital Ratio (MRQ) 3
  Total Debt to Equity (MRQ) 0
  Tangible Leverage Ratio (MRQ) 0.53
  Asset Turnover Ratio (TTM) 0
  Inventory Turnover Ratio (TTM) 1.47





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com